PDF
ZENODO
Published
2025-11-07
Section
Articles
How to Cite
How to Cite
MEDA VA ICHAK YARA KASALLIGI: ETIOLOGIYASI, PATOGENEZI, KLINIK BELGILARI,DIAGNOSTIKASI VA DAVOLASH USULLARI
Rajabov Doston
Zarmed Universiteti, Buxoro kampusi, davolash ishi fakulteti talabasi
Muazzamov Bobur
tibbiyot fanlari nomzodi, Dotsent
Keywords: Gastric ulcer, intestinal ulcer, Helicobacter pylori, aspirin, COX-1, molecular pathogenesis, treatment.
Abstract
This scientific article provides a comprehensive overview of the etiology, pathogenesis, clinical features, diagnosis, and modern treatment methods of gastric and intestinal ulcer diseases. Helicobacter pylori bacteria and nonsteroidal anti-inflammatory drugs, especially aspirin, are analyzed as significant factors in the development of these diseases. Molecular mechanisms of pathogenesis, including the disruption of prostaglandin synthesis and alterations in the activity of COX-1 and COX-2 enzymes, are thoroughly explained.
References
1. Sachs G, Howden CW. Peptic ulcer disease. Med Clin North Am. 2007;91(5): 1135-1150.
2. Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report. Gut. 2017;66(1):6-30.
3. Lanas A. Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. Arthritis Res Ther. 2009;11(Suppl 2):S2.
4. Wallace JL. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself? Physiol Rev. 2008;88(4):1547-1565.
5. Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 1993;104(6):1832-1847.
6. Lanza FL. A guideline for the treatment and prevention of NSAID-induced ulcers. Am J Gastroenterol. 1998;93(11):2037-2046.
7. Tarnawski AS. Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig Dis Sci. 2005;50(Suppl 1):S24-S33.
8. Szabo S. Molecular mechanisms of gastroduodenal mucosal defense and repair: translation to clinical therapeutics. Am J Med. 1995;98(2A):31S-41S.
9. Rainsford KD. Aspirin and the salicylates. Inflammopharmacology. 2004;12(1-2):3-8.
